APRILE, GIANNA
 Distribuzione geografica
Continente #
NA - Nord America 149
AS - Asia 121
EU - Europa 44
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 13
AF - Africa 2
Totale 349
Nazione #
US - Stati Uniti d'America 142
SG - Singapore 57
HK - Hong Kong 25
CN - Cina 16
IT - Italia 14
RU - Federazione Russa 11
VN - Vietnam 11
BR - Brasile 9
DE - Germania 5
JP - Giappone 5
CA - Canada 3
GB - Regno Unito 3
BD - Bangladesh 2
CZ - Repubblica Ceca 2
ES - Italia 2
FR - Francia 2
KE - Kenya 2
MX - Messico 2
BB - Barbados 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
FI - Finlandia 1
HN - Honduras 1
ID - Indonesia 1
IN - India 1
IQ - Iraq 1
LT - Lituania 1
NL - Olanda 1
NP - Nepal 1
PE - Perù 1
SE - Svezia 1
TR - Turchia 1
Totale 329
Città #
Singapore 40
Hong Kong 25
San Jose 22
Santa Clara 10
Ashburn 9
Beijing 9
Council Bluffs 7
New York 5
Rome 5
Hanoi 4
Milan 4
Tokyo 4
Brooklyn 3
Dallas 3
Denver 3
Ho Chi Minh City 3
Arlington 2
Birmingham 2
Brno 2
Buffalo 2
Frankfurt am Main 2
London 2
Los Angeles 2
Nairobi 2
Newark 2
Orem 2
Vimercate 2
Amsterdam 1
Ankara 1
Aparecida de Goiânia 1
Bady Bassitt 1
Belmont 1
Boardman 1
Bogotá 1
Bridgetown 1
Chennai 1
Chiclayo 1
Cirebon 1
Clayton 1
Cleveland 1
Divinópolis 1
Erbil 1
Fourques 1
Great Neck 1
Guarujá 1
Haiphong 1
Horizonte 1
Iztapalapa 1
Mexico City 1
Minsk 1
Mississauga 1
Montreal 1
Munich 1
Naperville 1
Nuremberg 1
Porto Seguro 1
Provo 1
Quito 1
Rahway 1
Redondo Beach 1
Richmond Hill 1
Rochester 1
San Francisco 1
San Pedro Sula 1
Santiago 1
St Louis 1
Summerfield 1
São Paulo 1
The Dalles 1
Tupã 1
Turku 1
Uberlândia 1
Washington 1
Totale 224
Nome #
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ?BRAF BeCool? study 119
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: The Colon Life nomogram 80
Single-agent panitumumab in frail elderly patients with advanced RAS and BRAF wild-type colorectal cancer: Challenging drug label to light up new hope 71
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients with RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation 70
Modified FOLFOXIRI plus panitumumab (mFOLFOXIRI/PAN) versus mFOLFOX6/PAN as initial treatment of patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer (mCRC): Results of the phase III randomized TRIPLETE study by GONO 9
Totale 349
Categoria #
all - tutte 1.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.440


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202410 0 0 0 0 0 0 6 0 0 0 0 4
2024/202595 1 23 8 3 2 4 6 7 15 16 5 5
2025/2026174 17 10 22 13 21 2 28 15 19 20 5 2
2026/202770 9 16 38 7 0 0 0 0 0 0 0 0
Totale 349